DP303c
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for DP303c, covering 2022-04-19 to 2024-09-05. Get the full timeline:
Most recent: Clinical Trial Update: A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma [Phase 1, Phase 2]